Please login to the form below

Not currently logged in
Email:
Password:

Life Sciences Strategy

This page shows the latest Life Sciences Strategy news and features for those working in and with pharma, biotech and healthcare.

UK announces new ten-year Life Sciences Vision to support life sciences sector

UK announces new ten-year Life Sciences Vision to support life sciences sector

UK government has launched a £200m life sciences investment programme to support innovative life sciences companies. ... The UK government has outlined a new strategy for its life sciences sector, aiming to ‘build on the successes of COVID-19

Latest news

  • We've got this! We've got this!

    Our industry has evolved before and we will again. Recently, I ran a webinar about strategy in the life sciences after COVID-19.It attracted a lot of interest and gave ... If those threats, and the many others we could think of, don’t give life

  • Johnson pledges £200m cash injection into UK’s life sciences sector Johnson pledges £200m cash injection into UK’s life sciences sector

    The life sciences is a key component of this and we must continue to implement the life sciences industrial strategy,” he added. ... edge health and life sciences companies” can get money into companies as soon as possible.”.

  • Illumina sets up first ex-US accelerator site in Cambridge Illumina sets up first ex-US accelerator site in Cambridge

    between Cambridge, Oxford and London into a go-to location for life sciences companies. ... Professor Sir John Bell, lead for the UK Life Sciences Industrial Strategy, said the new accelerator “will undoubtedly contribute to the UK’s life sciences

  • UK life sciences gets some Brexit relief with £1.3bn sector deal UK life sciences gets some Brexit relief with £1.3bn sector deal

    The government's sector deals are part of its industrial strategy aimed at boosting UK productivity, and this latest one is a welcome endorsement for the UK life sciences sector in ... The sector deal is an important step towards fully implementing the

  • Brexit migration measures threaten UK clinical research Brexit migration measures threaten UK clinical research

    It says: “The UK is recognised as a global leader in life sciences and clinical research. ... The company also says the government must strike a balance between limiting migration levels and ensuring that the UK has the skills to deliver the Life

More from news
Approximately 8 fully matching, plus 43 partially matching documents found.

Latest Intelligence

  • Well-funded life sciences firms are making long-term progress – and their investors are too Well-funded life sciences firms are making long-term progress – and their investors are too

    to the pandemic and other diseases, as well as enjoy surging returns, but it has also provided them with a different life sciences investment strategy. ... For too long, investment in life sciences has been swallowed up by the less versatile big

  • The science of the deal The science of the deal

    the real world of high uncertainty, asymmetric, R&D deals in the life sciences. ... Professor Brian D Smith(brian.smith@pragmedic.com) is an author, academic and advisor specialising in the evolution of business models and strategy in the life sciences

  • The UK’s new medicines pricing deal – opportunities and risks for pharma The UK’s new medicines pricing deal – opportunities and risks for pharma

    in practice have been picked up by the Office of Life Sciences (OLS) in their annual Life Sciences Competitiveness Indicators. ... There is the opportunity for industry to link VPAS and the life sciences strategy as VPAS itself doesn’t really do this,

  • Case study: Unleashing the ‘British Biotiger’ Case study: Unleashing the ‘British Biotiger’

    Ultimately, this strategy secured us a seat at the table for shaping the post-Brexit life sciences sector while simultaneously reassuring colleagues from across Europe and our global leadership team that ... Following this engagement, five of the Life

  • In conversation with Pfizer’s Erik Nordkamp In conversation with Pfizer’s Erik Nordkamp

    The Life Sciences Industrial Strategy could increase the speed with which new medicines and vaccines are made available across the UK, if implemented in full and with the involvement and commitment ... We have also joined forces with Swansea University

More from intelligence
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest appointments

  • AZ's Lisa Anson elected president of ABPI AZ's Lisa Anson elected president of ABPI

    She brings further pharmaceutical management experience from California-based Salick Health Care, where she was vice president of strategy, and management consultancy expertise from KPMG. ... Lisa will play a leading role as we negotiate the future of

  • Merck KGaA appoints Isabel De Paoli as communications head Merck KGaA appoints Isabel De Paoli as communications head

    Isabel De Paoli (pictured) is currently head of group strategy at the German life sciences, health and materials company and will officially step into her new role when Huber's tenure ... ends. Until then she will spend her time preparing for her new

  • New health ministers and re-appointments after reshuffle New health ministers and re-appointments after reshuffle

    State for Life Sciences; and David Prior, Parliamentary Under Secretary of State for NHS Productivity (Lords). ... the uptake of new drugs and med tech, and the government's life sciences industrial strategy.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • What do NHS changes and the Life Sciences Vision mean for medicines? What do NHS changes and the Life Sciences Vision mean for medicines?

    The launch of a new life sciences strategy is an important and positive step for industry. ... In contrast to the 2017 Life Sciences Industrial Strategy, the LSV is a Government publication endorsed by the Department of Health and Social Care (DHSC) and

  • Let's be ambitious for patients and life sciences investment in Global Britain Let's be ambitious for patients and life sciences investment in Global Britain

    Sadly, 12 years on, the 2017 Life Sciences Industrial Strategy could only restate the challenge: “Evidence demonstrates that access to and diffusion of products in the NHS is often slower than ... The Government’s 2019 election manifesto pledged to

  • Hanover Communications Hanover Communications

    Let's be ambitious for patients and life sciences investment in Global Britain. ... Sadly, 12 years on, the 2017 Life Sciences Industrial Strategy could only restate the challenge: “Evidence demonstrates that access to and diffusion of products in the

  • Unique forum will unite NHS and industry to drive innovation

    The Life Sciences Industrial Strategy made it clear that collaboration between the NHS and industry is essential to foster innovation. ... outline their strategic vision and what role the life sciences sector can play in supporting it          

  • Life at the end of the Brexit tunnel

    Sir John Bell outlined the Life Sciences Industrial Strategy, which includes £160 million of funding to support the health sector, including the NHS. ... The upbeat tone of the announcement was underpinned by the government's financial commitment to the

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...